ZOTA HEALTH CARE LTD.

NSE : ZOTABSE : ISIN CODE : INE358U01012Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( )0 0
NSE485.00-1.4 (-0.29 %)
PREV CLOSE( ) 486.40
OPEN PRICE ( ) 485.00
BID PRICE (QTY) 485.00 (1)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 14585
TODAY'S LOW / HIGH( ) 481.05 491.00
52 WK LOW / HIGH ( )271.95 555
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax-46.91124.35-3.6538.6278.56
Adjustment131.1626.6214.5010.620.07
Changes In working Capital-82.9119.71-19.1217.31-87.88
Cash Flow after changes in Working Capital1.34170.67-8.2766.55-9.25
Cash Flow from Operating Activities-20.06133.32-8.9055.57-32.47
Cash Flow from Investing Activities147.04-266.5238.20-35.4288.25
Cash Flow from Financing Activities-138.82142.73-24.19-28.74-63.46
Net Cash Inflow / Outflow-11.849.535.12-8.59-7.68
Opening Cash & Cash Equivalents22.9913.468.3516.9424.62
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations0.00-0.010.00NANA
Closing Cash & Cash Equivalent11.1522.9913.468.3516.94

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.